Telix Pharmaceuticals Limited today announces that its prostate cancer PET[1] imaging agent Illuccix® (kit for the preparation of gallium-68 gozetotide injection) has been granted marketing ...

Entrepreneurial CMO 50 list recognizes fifty chief marketers whose approach to driving growth is charting new paths.